ERBB2 and breast carcinoma: Ramamoorthi G observed that HER2-DC1 combined with T-DM1 increased the levels of tumor-infiltrating CD4 and CD8 T, B, natural killer T, and NK cells in HER2 breast cancer-bearing mice and promoted complete tumor regression (35).